methoxyhydroxyphenylglycol has been researched along with deoxycytidine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Guo, B; Meng, F; Sun, Y; Wang, J; Wei, J; Yuan, J; Zhong, Z | 1 |
1 other study(ies) available for methoxyhydroxyphenylglycol and deoxycytidine
Article | Year |
---|---|
CD44-targeting hydrophobic phosphorylated gemcitabine prodrug nanotherapeutics augment lung cancer therapy.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Deoxycytidine; Disulfides; Gemcitabine; Humans; Hyaluronan Receptors; Lung; Lung Neoplasms; Methoxyhydroxyphenylglycol; Micelles; Prodrugs | 2022 |